Nvidia’s Kimberly Powell: We are reinventing the doctor experience - Financial Times

NVIDIA executive Kimberly Powell discusses how artificial intelligence is reshaping the doctor experience in healthcare. As VP of healthcare at NVIDIA, Powell emphasizes that AI can significantly redu... Read original →

NVIDIA’s healthcare push isn’t just about AI—it’s a strategic embed of its GPU architecture into clinical workflows. Technically, this fuels sustained demand for H100/B100 chips in 3D imaging and multimodal analytics, indirectly pressuring EUV capacity toward AI accelerators. HIPAA compliance mandates on-prem or sovereign cloud deployments, raising barriers for smaller players and reinforcing NVIDIA’s ecosystem moat with partners like Menlo Ventures. Competitively, AMD’s MI300X targets drug discovery but lacks integrated medical software; Google Health struggles with trust in core clinical settings due to public-cloud skepticism. Over the next 12–24 months, AI agents will redefine EHR architectures, elevating GPUs from compute peripherals to healthcare infrastructure—control over clinical data interfaces will dictate who sets the standards for medical AI.